B
Bernd Sommerauer
Researcher at Bayer
Publications - 2
Citations - 1961
Bernd Sommerauer is an academic researcher from Bayer. The author has contributed to research in topics: Aflibercept & Tobramycin. The author has an hindex of 2, co-authored 2 publications receiving 1654 citations.
Papers
More filters
Journal ArticleDOI
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Jeffrey S. Heier,David M. Brown,Victor Chong,Jean-François Korobelnik,Peter K. Kaiser,Quan Dong Nguyen,Bernd Kirchhof,Allen C. Ho,Yuichiro Ogura,George D. Yancopoulos,Neil Stahl,Robert Vitti,Alyson J. Berliner,Yuhwen Soo,Majid Anderesi,Georg Groetzbach,Bernd Sommerauer,Rupert Sandbrink,Rupert Sandbrink,Christian Simader,Ursula Schmidt-Erfurth +20 more
TL;DR: It is demonstrated that aflibercept is an effective treatment for AMD, with the every-2-month regimen offering the potential to reduce the risk from monthly intravitreal injections and the burden of monthly monitoring.
Journal ArticleDOI
Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: Comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging
David A. Richard,Sanda Nousia-Arvanitakis,Veronika Sollich,Barbara Hampel,Bernd Sommerauer,Urs B. Schaad +5 more
TL;DR: Ciprofloxacin appears to be safe and effective for use in young patients with bronchopulmonary exacerbation of cystic fibrosis.